2021 Publications

  1. Ridell P, Moshkelgosha S, Levy L, Chang N, Pal P, Halloran K, Halloran PF, Parkes M, Singer LG, Keshavjee S, Marginu T and Juvet S. IL-6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndrome. Clinical & Translational Immunology;10(2):e1243.
  2. Halloran PF. Integrating molecular and histologic interpretation of transplant biopsies. Clinical Transplantation 2021;35(4): e14244.
  3. Hruba P, Madill-Thomsen K, Mackova M, Maluskova J, Voska L, Slatinska J, et al. Three-months course of intragraft transcriptional changes in kidney allografts with early histological minimal injury. Transpl Int. 2021. doi: 10.1111/tri.13856. Online ahead of print.
  4. Gupta G et al. Correlation of Donor-derived Cell-free DNA with Histology and Molecular Diagnoses of Kidney Transplant Biopsies. Transplantation 2021. Accepted. doi: 10.1097/TP.0000000000003838.
  5. Veceric-Haler V, Kojc N, Sever M, Zver S, Svajger U, Pozenel P, et al. Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy. Frontiers in Medicine. 2021;8(1138).
  6. Madill-Thomsen KS, Bohmig GA, Bromberg J, Einecke G, Eskandary F, Gupta G, Hidalgo LG, Myslak M, Viklicky O, Perkowska-Ptasinska A, Halloran PF and the INTERCOMEX Investigators. Donor-specific antibody is associated with increased expression of rejection transcripts in renal transplant biopsies classified as no rejection. J Am Soc Nephrol 2021;32(7): DOI: https://doi.org/10.1681/ASN.2021040433
  7. Halloran PF, Madill-Thomsen KS, Aliabadi-Zuckerman AZ, Cadeiras M, Crespo-Leiro MG, Depasquale E, Deng M, Gokler J, Kim DH, Kobashigawa J, Macdonald P, Potena L, Shah K, Stehlik J, and Zuckermann A. Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes. Journal of Heart and Lung Transplantation 2021. 2021 Aug 26;S1053-2498(21)02458-X.